Brief Articles
J ournal of Medicinal Chemistry, 1999, Vol. 42, No. 9 1671
Meth yl 1-(4-Ch lor op h en yl)-9H-p yr id o[3,4-b]in d ole-3-
ca r boxyla te (4a ). A suspension of 3a (1.56 g, 4.58 mmol) and
sulfur (0.29 g, 9.16 mmol) in xylene (30 mL) was heated at
reflux for 8 h and allowed to cool to room temprature, excess
sulfur was filtered off, and the filtrate was concentrated in
vacuo. The residue was crystallized to afford 4a , 0.36 g (37%).
conditions of adult male and female worms observed. The
micro- and macrofilaricidal actions were assessed as described
for A. viteae.
3. B. m a la yi: The 6-week-old male Mastomys were infected
by inoculum of 50 infective larvae of B. malayi recovered from
infected mosquitoes (Aedes aegybti).36 Method of screening of
compounds was similar to that of A. viteae except blood was
examined up to day 92 posttreatment. Animals were sacrificed
on day 92 for adult worm recovery.
IR (KBr): 3236, 3010, 2822, 1716, 1600, 1362, 1250 cm-1
.
,
MS: m/z (relative intensity) 338 (M, Cl37, 14.8), 336 (M, Cl35
1
39.9), 278 (100), 214 (20). H NMR (400 MHz, CDCl3): δ 8.9
(s, 1H, H-4), 8.8 (bs, 1H, indole NH), 8.25 (d, 1H, ArH, J ) 8
Hz), 7.9 (d, 2H, ArH, J ) 8 Hz), 7.64-7.50 (m, 4H, ArH), 7.4
(t, 1H, ArH, J ) 8 Hz), 4.06 (s, 3H, OCH3). Similarly,
compounds 4b-i were synthesized.
Ack n ow led gm en t. We are indebted to RSIC, Luc-
know, for providing spectroscopic and analytical data.
One of us (S.K.S.) is grateful to CSIR for the award of
Senior Research Fellowship, and A.A. and N.F. thank
CSIR and ICMR for the award of Research Associate,
respectively.
1-(4-Ch lor op h en yl)-3-(h yd r oxym eth yl)-9H-p yr id o[3,4-
b]in d ole (5a ). A solution of 4a (0.4 g, 1.18 mmol) in dry THF
(8 mL) was added dropwise to the stirred solution of LiAlH4
(0.09 g, 2.37 mmol) in dry THF (20 mL) at ambient temper-
ature. The reaction mixture was refluxed for 8 h and was
allowed to remain at room temperature. The complex was
decomposed by 10% aqueous NaOH solution, solid that sepa-
rated was filterated and washed with water, and then filterate
was concentrated in vacuo. The residue thus obtained was
filtered, washed with water, and crystallized to provide 5a ,
0.29 g (80%). IR (KBr): 3180, 3060, 2800, 1630, 1490, 1240,
Refer en ces
(1) National workshop on operational constrains and their feasable
solutions for efficient functions of national filaria control pro-
gram units in the country, NICD, Delhi, India, December 1991.
(2) Ottesen, E. A.; Ramachandran, C. P. Lymphatic filariasis
infection and disease: control strategies. Parasitol. Today 1995,
2, 129-131.
(3) Cao, W.; Ploeg, C. P. B.; Ren, Z.; Habbema, J . D. F. Sucess
against lymphatic filariasis. World Health Forum 1997, 18, 17-
20.
(4) Sharma, S. Vector borne diseases. Prog. Drug Res. 1990, 35,
365-485.
(5) Simonsen, P. E.; Meyrowitsch, D. W.; Makunde, W. H. Bancrof-
tian filariasis: long-term effect of the DEC provocative day tcol
on microfilaraemia Trans. R. Soc. Trop. Med. Hygiene 1997, 91,
290-293.
(6) Bennett, J . L.; Williams, J . F.; Dave, V. Pharmacology of
Ivermectin. Parasitol. Today 1988, 4 (8), 226-228.
(7) Ginger, C. D. Advances in Filarial Chemotherapy and Screening.
Parasitol. Today 1986, 2 (2), 38-40.
(8) Loiseau, P. M.; Depreux, P. In vitro antifilarial evaluation of
phenoxycyclohexane derivatives. Ann. Trop. Med. Parasitol.
1993 87 (6) 469-476.
(9) Chauhan, P. M. S.; Chatterjee, R. K. Synthesis of 1,3-substituted
pyrazoles as possible antifilarial agents. Indian J . Chem. 1994,
33B, 32-37.
(10) Srivastava, S. K.; Chauhan, P. M. S.; Agarwal, S. K.; Bhaduri,
A. P.; Singh, S. N.; Fatma, N.; Chatterjee, R. K.; Bose, C.;
Srivastava, V. M. L. Syntheses and antifilarial profile of 5-amino
and 5,8-diamino isoquinoline derivatives: A new class of anti-
filarial agents. Bioorg. Med. Chem. Lett. 1996, 6 (22), 2623-
2628.
1010, 720 cm-1. MS: m/z (relative intensity): 310 (M, Cl37
,
4.5), 308 (M, Cl35, 54.9), 306 (100), 278 (47.5). H NMR (400
MHz, CDCl3 + DMSO-d6): δ 8.46 (bs, 1H, indole NH), 8.12
(d, 1H, ArH, J ) 8 Hz), 8.1-8.0 (m, 3H, ArH), 7.7-7.49 (m,
4H, ArH), 7.24 (t, 1H, ArH, J ) 8 Hz), 4.96 (s, 2H, CH2), 3.7
(s, 1H, OH). Compounds 5b-i were synthesized using a
similar procedure.
1
1-(4-Ch lor op h en yl)-9H -p yr id o[3,4-b]in d ole-3-ca r b ox-
a m id e (6a ). A solution of 4a (0.93 g, 2.75 mmol) in aqueous
ammonia solution (8 mL) and methanol (10 mL) was heated
at 80 °C under pressure in a steel bomb for 8 h. The reaction
mixture was concentrated, and solid thus separated was
filtered and on crystallization gave 6a , 0.33 g (37%). IR
(KBr): 3442, 3366, 3220, 1664, 1386, 742 cm-1. MS m/z
(relative intensity): 323 (M, Cl37, 9.5), 321 (M, C135, 25.7), 278
1
(100), 242 (51.1). H NMR (400 MHz, CDCl3): δ 8.94 (s, 1H,
H-4), 8.74 (bs, 1H, indole NH), 8.22 (d, 1H, ArH, J ) 8 Hz),
8.04 (bs, 1H, NH of NH2), 7.95 (d, 2H, ArH, J ) 8 Hz), 7.7-
7.5 (m, 4H, ArH), 7.38 (t, 1H, ArH, J ) 8 Hz), 5.62 (bs, 1H,
NH of NH2). Compounds 6b-i were obtained by using the
same method.
1-(4-Ch lor op h en yl)-9H-p yr id o[3,4-b]in d ole-3-ca r boxy-
lic Acid Hyd r a zid e (7a ). Compound 4a (1 g, 2.97 mmol) and
hydrazine hydrate (1.5 mL, 48.2 mmol) were refluxed in
ethanol (50 mL) for 4 h. The reaction mixture was concen-
trated, and solid thus separated was filtered and on crystal-
lization gave 7a , 0.72 g (72%). IR (KBr): 3930, 3886, 2369,
1623, 1320, 836 cm-1. MS m/z (relative intensity): 338 (M, Cl37,
(11) Singh, S. N.; Bhatnagar, S.; Fatma, N.; Chauhan, P. M. S.;
Chatterjee, R. K. Antifilarial activity of a synthetic marine
alkaloid, aplysinopsin (CDRI Compound 92/138). Trop. Med. Int.
Health 1997, 2 (6), 535-543.
(12) Tewari, S.; Chauhan, P. M. S.; Bhaduri, A. P.; Singh, S. N.;
Fatma, N.; Chatterjee, R. K.; Srivastava, V. M. L. 11′-Dicyano-
2-substituted ethylenes: A new class of glucose uptake inhibitors
in antifilarial chemotherapy. Bioorg. Med. Chem. Lett. 1997, 7
(14), 1891-1896.
1
10.0), 336 (M, Cl35, 26.9), 277 (29.3), 130 (100). H NMR (400
MHz, CDCl3 + DMSO-d6): δ 8.83 (s, 1H, H-4), 8.75 (bs, 1H,
indole NH), 8.3-8.15 (m, 2H, ArH), 7.8-7.5 (m, 4H, ArH), 7.4-
7.2 (m, 2H, ArH), 4.2-3.5 (bs, 3H, NH and NH2). Similarly,
compounds 7c, 7d , 7f, 7h , and 7i were synthesized.
(13) Sharma, S. Design of new drugs for helminth diseases: Lead
optimization in benzimidozole. Adv. Drug Res. 1994, 25, 103-
172.
(14) Townsend, L. B.; Wise D. S. The synthesis and chemistry of
certain anthelmintic benzimidazoles. Parasitol. Today 1990, 6,
107-112.
Ma ter ia ls a n d Meth od s for Biologica l Eva lu a tion . 1.
A. vitea e: A. viteae infection was transmitted to 6-week-old
male M. coucha through the vector Ornithodorus moubata by
the method as reported in the literature.39 The micro- and
macrofilaricidal activities of the compounds were assessed
against A. viteae in M. coucha at 50 mg/kg intraperitoneally
and/or 200 mg/kg orally for 5 consecutive days according to
the literature method.40,41
2. L. ca r in ii : The infection was transmitted to 6-week-old
cotton rats (S. hispidus) through the vector Liponyssus bacoti
by the literature method.42 Animals showing 250 or more
microfilariae/5 mm of blood were chosen for screening. Blood
samples of experimental and control animals were examined
for microfilariae before starting the treatment and thereafter
at weekly intervals till day 42. All the compounds were given
30 mg/kg intraperitoneally for 5 consecutive days. On day 42,
all the treated and control animals were sacrified and the
(15) Agarwal, A.; Agarwal, S. K.; Bhakuni, D. S.; Gupta, S.; Katiyar,
J . C. Antiparasitic agents: Part VIII - Synthesis of 1,6- and 1,8-
disubstituted-9H-pyrido[3,4-b]indoles and 2-substituted-1(3),10-
dihydro-9- phenylpyrido[3,4-b]imidazo[4,5-b]indoles and their
anthelmintic activity. Indian J . Chem. 1989, 28B, 943-949.
(16) Agarwal, A.; Agarwal, S. K.; Bhakuni, D. S. Antiparasitic
agents: Part X-Synthesis of 2,7-disubstituted-1,6-dihydropyrido-
[3,4-b]imidazo[4,5-e]indoles as anthelmintic agents. Indian J .
Chem. 1990, 29B, 843-847.
(17) Agarwal, A.; Agarwal, S. K.; Bhakuni, D. S.; Gupta, S.; Katiyar,
J . C. Antiparasitic agents: Part XIII - Synthesis and anthelm-
intic activity of 6- and 8-(2,4-dioxoquinazolin-3-yl)-l-substituted-
9H-pyrido[3,4-b]indoles, 6- and 8-(2-methyl-5-acetamidobenz-
imidazol-1-yl)-1-substituted-9H-pyrido [3,4-b]indoles and 6-[2-
carbomethoxyamino-5-N,N′-dicarbo-methoxyquanidino)benz-
imidazol-1-yl]-1-phenyl-9H-pyrido[3,4-b]indole. Indian J . Chem.
1990, 29B, 848-854.